期刊文献+

大鼠C6脑胶质瘤超小型超顺磁氧化铁灌注成像与Gd-DTPA灌注成像对比 被引量:2

Comparison of ultrasmall superparamagnetic iron oxide and Gd-DTPA as contrast agents for MR perfusion weighted imaging in rat C6 brain gliomas
下载PDF
导出
摘要 目的比较大鼠C6脑胶质瘤超小型超顺磁氧化铁(USPIO)PWI与Gd-DTPA PWI的异同点,观察USPIOPWI评价胶质瘤微血管水平血流灌注的可行性。方法对30只雄性SD大鼠接种C6胶质瘤,并随机分成2组:USPIOPWI组及Gd-DTPA PWI组,于接种后12天行常规MR及PWI扫描,之后行SE T1 W或FSE T2 W增强扫描。于肿瘤最大层面选取ROI,分别于肿瘤强化区及对侧正常脑实质区获取灌注曲线,计算ROI的最大信号强度下降百分比(SRRmax)、相对血流容积(rBV)及肿瘤组织与正常脑组织rBV比值(QrBV)和SRRmax比值(QSRRmax),同时取肿瘤组织行HE及GFAP染色。结果 USPIO PWI组及Gd-DTPA PWI组肿瘤组织rBV和SRRmax值均明显高于对侧正常脑组织(P<0.05)。USPIO PWI组肿瘤组织rBV和SRRmax均高于Gd-DTPA PWI组(P<0.05)。USPIO PWI组与Gd-DTPA PWI组的肿瘤组织与正常脑组织QrBV和QSRRmax值之间差异有统计学意义(P<0.05)。结论与Gd-DTPA PWI相比,USPIO PWI具有更加明显的灌注效应,有助于评估肿瘤微循环。 Objective To compare the similarities and differences between ultrasmall superparamagnetic iron oxide(USPIO) PWI and Gd-DTPA PWI,and to observe the feasibility of USPIO PWI in evaluating tumor angiogenesis.Methods C6 glioma model in 30 male rats were established and divided into two groups in random: USPIO PWI group and Gd-DTPA PWI group.Conventional MR imaging and PWI were performed at 12 days of tumor age.USPIO PWI and Gd-DTPA PWI were performed,respectively.Imaging sequences included SE T1W,FSE T2W,EPI PWI.ROIs at the largest section of tumor were selected in each rat.Perfusion curves of tumors in enhancement areas and contralateral normal brain tissue were obtained,and the maximum signal reduction ratio(SRRmax),regional blood volume(rBV) and the ratio of each parameter(QrBV,QSRRmax) between the two ROIs were calculated.Histopathology examination was performed with HE staining and immunohistochemistry of GFAP.Results Statistical differences of the rBV and SSRmax were found between tumor tissue and normal brain tissue in both USPIO PWI and Gd-DTPA PWI group(P0.05).The rBV and SSRmax in USPIO PWI group were higher than those in Gd-DTPA PWI group(P0.05).Statistical difference of the QrBV and QSRRmax were also found between the two groups(P0.05).Conclusion USPIO PWI can demonstrate more obvious perfusion effect than Gd-DTPA,therefore being helpful to the evaluation of tumor microcirculation.
出处 《中国医学影像技术》 CSCD 北大核心 2011年第3期444-448,共5页 Chinese Journal of Medical Imaging Technology
关键词 胶质瘤 灌注成像 钆喷酸葡胺 氧化铁钠米粒子 Glioma Perfusion imaging Gadolinium DTPA Ferumoxtran-10
  • 相关文献

参考文献11

  • 1Kieran MW. Anti-angiogenic chemotherapy in central nervous system tumors. Cancer Treat Res, 2004,117:337-349.
  • 2那婧,谢德轩,刘鹏飞,周洋.脑胶质瘤MR灌注成像和病理分级对照研究[J].中国临床医学影像杂志,2006,17(3):121-123. 被引量:6
  • 3张龙江 ,包颜明 ,祁吉 .对比剂首过MR灌注成像在脑胶质瘤中的应用价值[J].中国医学影像技术,2004,20(5):810-813. 被引量:23
  • 4De Bazelaire C, Siauve N, Fournier L, et al. Comprehensive model for simultaneous MRI determination of perfusion and per- meability using a bloodpool agent in rats rhabdomyosarcoma. Eur Radiol, 2005,15(12) :2497-2505.
  • 5Kostourou V, Robinson SP, Whitley GS, et al. Effects of overexpression of dimethylarginine dimethylaminohydrolase on tumor angiogenesis assessed by susceptibility magnetic resonance imaging. Cancer Res, 2003,63(16):4960 4966.
  • 6Cha S, Johnson G, Wadghiri YZ, et al. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology. Magn Reson Med, 2003,49(5):848-855.
  • 7Jahan N, Narayanan P, Rockall A. Magnetic resonance lymphography in gynaecological malignancies. Cancer Imaging, 2010, 16 (10) :85-96.
  • 8Su MY, Taylor JA, Villarreal LP, et al. Prediction of gene therapyinduced tumor size changes by the vascularity changes measured using dynamic contrastenhanced MRI. Magn Reson Imaging, 2000,18(3):311-317.
  • 9Varallyay CG, Muldoon LL, Gahramanov S, et al. Dynamic MRI using iron oxide nanoparticles to assess early vascular effects of antiangiogenic versus corticosteroid treatment in a glioma model. J Cereb Blood Flow Metab, 2009,29(4) :853-860.
  • 10Allkemper T, Heindel W, Kooijman H, et al. Effect of field strengths on magnetic resonance angiography: comparison of an ultrasmall superparamagnetic iron oxide blood-pool contrast agent and gadopentetate dimeglumine in rabbits at 1.5 and 3.0 tesla. Invest Radiol, 2006,41(2) :97-104.

二级参考文献34

  • 1[1]Villringer A,Rosen BR,Belliveau JW,et al.Dynamic imaging with lanthanide chelates in normal brain:contrast due to magnetic susceptibility effects[J].Magn Reson Med,1998,6(2):164-174.
  • 2[2]Cha S,Knopp EA,Johnson CT,et al.Dynamic contrast-enhamed T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin[J].AJNR,2000,21(5):881-890.
  • 3[3]Cha S,Knopp EA,Johnson CT,et al.Intracranial mass lesions:dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging[J].Radiology,2002,223(1):11-29.
  • 4[4]Knopp EA,Cha S,Johnson CT,et al.Glial neoplasms:dynamic contrast-enhanced T2*-weighted MR imaging[J].Radiology,1999,211(3):791-798.
  • 5[5]Jezzard P.Advances in perfusion MR imaging[J].Radiology,1998,208(1):296-299.
  • 6[6]Petrella JR,Provenzale JM.MR perfusion imaging of the brain:techniques and applications[J].AJR,2000,175(1):207-219.
  • 7[7]Shin JH,Lee HK,Kwun BD,et al.Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas:preliminary results[J].AJR,2002,179(3):783-789.
  • 8[8]Sugahara T,Korogi Y,Kochi M,et al.Perfusion-sensitive MR imaging of gliomas:comparison between gradient-echo and spin-echo echo-planar imaging technique[J].AJNR,2001,22(8):1306-1315.
  • 9[9]Cho SK,Na DG,Ryoo JW,et al.Perfusion MR imaging:clinical utility for the differential diagnosis of various brain tumors[J].Korean J Radiology,2002,3(3):171-179.
  • 10[10]Lee SJ,Kim JH,Kim YM,et al.Perfusion MR imaging in gliomas:Comparison with histologic tumor grade[J].Korean J Radiology,2001,2(1):1-7.

共引文献27

同被引文献26

  • 1丁建辉,曾蒙苏,薛琼,钟高仁,顾海雁,周康荣,沈继章,陈财忠.叶酸受体型MR对比剂在荷人胃癌裸鼠诊断价值的实验研究[J].中华放射学杂志,2005,39(8):882-886. 被引量:8
  • 2李康安,张锋,马勇杰,张贵祥,古宏晨,胡运胜,赵京龙,李玉洁.SPIO分子探针标记裸鼠肺腺癌移植瘤的磁共振成像及病理学初步研究[J].中国医学影像技术,2005,21(11):1655-1658. 被引量:10
  • 3刘影,李传福,张凯,侯金文,王茜,丛培新,郑金勇,孟祥水,冯德朝.星形细胞瘤各向异性分数值与其内部微结构的相关性分析[J].中华放射学杂志,2007,41(4):355-357. 被引量:7
  • 4Massart R.Preparation of aqueous magnetic liquids in alkalineand acidic media.IEEE Trans Magn,1981,17(2):1247-1249.
  • 5Ross JF,Chaudhuri PK,Ratnam M.Diffierenatial regulation offolate receptor isoforms in normal malignant tissues in vivo and inestablished cell lines.Cancer Res,1992,52(23):6708-6711.
  • 6Sun C,Sze R,Zhang MQ.Folic acid-PEG conjugated superpara-magnetic nanoparticles for targeted cellular uptake and detectionby MRI.Biomedical Materials Res A,2006,78(3):550-557.
  • 7Mikhaylova M,Kyung KD,Berry CC,et al.BSA immobilizationon amine-functionalized superparamagnetic iron oxide nanoparti-cles.Chem Mater,2004,16(12):2344-2354.
  • 8Ting-Jung C,Tsan-Hwang C,Yu-Chin H,et al.Targeted folicacid-PEG nanoparticles for noninvasive imaging of folate receptorby MRI.J Biomed Mater Res A,2008,87(1):165-175.
  • 9Agarwal A,Saraf S,Asthana A,et al.Ligand based dendriticsystems for tumor targeting.Int J Pharm,2008,350(1-2):3-13.
  • 10Konda SD,Aref M,Brechbiel M,et al.Development of a tu-mortargeting MR contrast agent using the high-affinity folat ereceptor:Work in progress.Invest Radiol,2000,35(1):50-57.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部